Home LiteratureArticle Details
PMID: 10403932 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid.

Clinical and experimental immunology ·Vol. 117 ·No. 1 ·1999-07-00 ·Pages 171-6

Bottomley MJ, Webb NJ, Watson CJ, Holt PJ, Freemont AJ, Brenchley PE

Abstract

This study was designed to investigate VEGF production from peripheral blood mononuclear cells (PBMC) from patients with rheumatoid arthritis (RA) compared with healthy controls and to identify the predominant cellular source in PBMC isolated from RA patients. The regulation of PBMC VEGF production by cytokines and synovial fluid (SF) was studied. PBMC were isolated from RA patients and healthy controls and stimulated with lipopolysaccharide (LPS), IL-1beta, IL-4, IL-6, IL-8, IL-10, TNF-alpha and transforming growth factor-beta (TGF-beta) isoforms for varying time points up to 72 h at 37 degrees C/5% CO2. The effect of SF on VEGF secretion by PBMC was also studied. Supernatant VEGF levels were measured using a flt-1 receptor capture ELISA. RA patients had significantly higher spontaneous production of VEGF compared with controls, and monocytes were identified as the predominant cellular source. RA PBMC VEGF production was up-regulated by TGF-beta isoforms and TNF-alpha and down-regulated by IL-4 and IL-10, with no effect observed with IL-1beta, IL-6 and IL-8. Antibody blocking experiments confirmed that TNF-alpha and not TGF-beta isoforms in SF increased VEGF secretion by RA PBMC. These results emphasize the importance of monocytes as a source of VEGF in the pathophysiology of RA. Several cytokines known to be present in SF can modulate the level of VEGF secretion, but the predominant effect of SF in VEGF up-regulation is shown to be dependent on TNF-alpha.

MeSH Terms
Arthritis, Rheumatoid/blood,immunology Autoimmune Diseases/blood,immunology Endothelial Growth Factors/metabolism Humans Interleukins/pharmacology Leukocytes, Mononuclear/drug effects,metabolism Lipopolysaccharides/pharmacology Lymphocyte Activation/drug effects Lymphokines/metabolism Synovial Fluid/chemistry Tumor Necrosis Factor-alpha/isolation & purification,pharmacology Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Interleukins Lipopolysaccharides Lymphokines Tumor Necrosis Factor-alpha Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bottomley M J
Immunology Research, Manchester Royal Infirmary, Manchester, UK.
Webb N J
Watson C J
Holt P J
Freemont A J
Brenchley P E
References (43)
43 references, click to expand
  1. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation.
    Lancet. 1981 Oct 17;2(8251):839-42 PMID: 6116956
  2. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.
    Circulation. 1995 Jul 1;92(1):11-4 PMID: 7788904
  3. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.
    Nature. 1987 Oct 15-21;329(6140):630-2 PMID: 2443857
  4. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
    J Invest Dermatol. 1995 Jul;105(1):44-50 PMID: 7615975
  5. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.
    Cancer Res. 1995 Sep 15;55(18):4140-5 PMID: 7545086
  6. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis.
    J Rheumatol. 1995 Sep;22(9):1624-30 PMID: 8523334
  7. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry.
    J Reprod Fertil. 1995 Nov;105(2):205-13 PMID: 8568762
  8. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    EMBO J. 1996 Jan 15;15(2):290-98 PMID: 8617204
  9. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro.
    Cancer Lett. 1996 Apr 19;102(1-2):209-15 PMID: 8603372
  10. Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
    Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2576-81 PMID: 8637916
  11. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells.
    J Biol Chem. 1996 May 10;271(19):11500-5 PMID: 8626709
  12. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
    Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1988-92 PMID: 8700872
  13. Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay.
    J Immunol Methods. 1996 Sep 27;196(2):199-209 PMID: 8841458
  14. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.
    J Biol Chem. 1996 Nov 8;271(45):28220-8 PMID: 8910439
  15. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.
    Clin Sci (Lond). 1998 Apr;94(4):395-404 PMID: 9640345
  16. SEPARATION OF WHITE BLOOD CELLS.
    Nature. 1964 Nov 21;204:793-4 PMID: 14235685
  17. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
    Clin Exp Immunol. 1988 Jul;73(1):88-92 PMID: 2458872
  18. Tumour necrosis factor in synovial exudates.
    Ann Rheum Dis. 1988 Sep;47(9):768-72 PMID: 3263088
  19. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.
    Proc Natl Acad Sci U S A. 1989 May;86(10):3803-7 PMID: 2786204
  20. Increased expression of p150,95 and CR3 leukocyte adhesion molecules by mononuclear phagocytes in rheumatoid synovial membranes. Comparison with osteoarthritic and normal synovial membranes.
    Arthritis Rheum. 1989 Aug;32(8):947-54 PMID: 2569874
  21. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.
    Proc Natl Acad Sci U S A. 1989 Oct;86(19):7311-5 PMID: 2798412
  22. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.
    Proc Natl Acad Sci U S A. 1990 Apr;87(7):2628-32 PMID: 2320579
  23. Rheumatoid arthritis. Pathophysiology and implications for therapy.
    N Engl J Med. 1990 May 3;322(18):1277-89 PMID: 2271017
  24. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
    Arthritis Rheum. 1991 Sep;34(9):1125-32 PMID: 1930331
  25. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.
    Science. 1992 Feb 21;255(5047):989-91 PMID: 1312256
  26. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.
    J Clin Invest. 1992 Aug;90(2):382-8 PMID: 1322938
  27. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
    Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579-86 PMID: 1417831
  28. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis.
    Exp Cell Res. 1993 Feb;204(2):356-63 PMID: 7679998
  29. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.
    Mol Biol Cell. 1993 Jan;4(1):121-33 PMID: 7680247
  30. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
    Blood. 1993 May 15;81(10):2767-73 PMID: 8490183
  31. Synovial tissue macrophages and joint erosion in rheumatoid arthritis.
    Ann Rheum Dis. 1994 Jan;53(1):39-44 PMID: 8311554
  32. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.
    J Biol Chem. 1994 Mar 4;269(9):6271-4 PMID: 8119973
  33. Macrophages and angiogenesis.
    J Leukoc Biol. 1994 Mar;55(3):410-22 PMID: 7509844
  34. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
    J Immunol. 1994 Apr 15;152(8):4149-56 PMID: 7511670
  35. Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
    J Exp Med. 1994 May 1;179(5):1517-27 PMID: 8163935
  36. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.
    J Exp Med. 1994 Jul 1;180(1):341-6 PMID: 8006592
  37. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.
    Circulation. 1994 Aug;90(2):649-52 PMID: 8044933
  38. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
    Lancet. 1994 Oct 22;344(8930):1105-10 PMID: 7934491
  39. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
    Lancet. 1994 Oct 22;344(8930):1125-7 PMID: 7934495
  40. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.
    Arthritis Rheum. 1994 Nov;37(11):1647-55 PMID: 7980676
  41. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells.
    J Biol Chem. 1995 Jan 6;270(1):308-12 PMID: 7814392
  42. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.
    Hypertension. 1995 May;25(5):913-7 PMID: 7737726
  43. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
    Science. 1983 Feb 25;219(4587):983-5 PMID: 6823562
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
1999-07-00
Pages
171-6
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1905470
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com